1T2J | A: | CRYSTAL STRUCTURE OF A HUMAN VH DOMAIN |
1WT5 | C:; D: | THE CRYSTAL STRUCTURE OF A HUMANIZED ANTIBODY FV 528 |
2A9M | H:; I: | STRUCTURAL ANALYSIS OF A TIGHT-BINDING FLUORESCEIN-SCFV; APO FORM |
2AGJ | L:1-107 | CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY |
2BX5 | A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M:; N:; O: | IS FR1 THE ANTIBODY'S ACHILLIES HEEL |
2D7T | L: | CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV |
2EIZ | A: | CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HW47Y)-HEN LYSOZYME COMPLEX |
2EKS | A: | CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV-HEN LYSOZYME COMPLEX |
2HP4 | A:; B: | COMPUTATIONAL DESIGN AND CRYSTAL STRUCTURE OF AN ENHANCED AFFINITY MUTANT HUMAN CD8-ALPHA-ALPHA CO-RECEPTOR |
2J12 | B: | AD37 FIBRE HEAD IN COMPLEX WITH CAR D1 |
2J1K | A:; B:; G:; J:; K:; O:; P:; T:; V:; X:; Y:; Z: | CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1 |
2KQM | A:; B: | SOLUTION STRUCTURE OF THE KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN |
2KQN | A:; B: | SOLUTION STRUCTURE OF THE AL-09 H87Y IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN |
2PYF | B:1-113 | CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1 |
2Q1E | A:; B:; C:; D: | ALTERED DIMER INTERFACE DECREASES STABILITY IN AN AMYLOIDOGENIC KAPPA1 BENCE JONES PROTEIN. |
2Q20 | A:; B: | STRUCTURE OF THE GERMLINE VK1 O18/O8 LIGHT CHAIN VARIABLE DOMAIN HOMODIMER |
2UZI | H:; L: | CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV COMPLEX |
2VH5 | H:; L: | CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) COMPLEX |
2VYR | E:; F:; G:; H:; I:; J:; K:; L: | STRUCTURE OF HUMAN MDM4 N-TERMINAL DOMAIN BOUND TO A SINGLE DOMAIN ANTIBODY |
2W0K | A:; B: | CRYSTAL STRUCTURE OF THE RECOMBINANT VARIABLE DOMAIN 6JAL2 |
2W0L | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE MUTANT H8P FROM THE RECOMBINANT VARIABLE DOMAIN 6JAL2 |
2WBW | B: | AD37 FIBRE HEAD IN COMPLEX WITH CAR D1 AND SIALIC ACID |
2X44 | D: | STRUCTURE OF A STRAND-SWAPPED DIMERIC FORM OF CTLA-4 |
2XTJ | B: | THE CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH 1D05 FAB |
2YBR | A:; D:; G: | CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN |
2YC1 | A:; D: | CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN |
2YSS | A: | CRYSTAL STRUCTURE OF HUMANIZED HYHEL-10 FV MUTANT(HQ39KW47Y)-HEN LYSOZYME COMPLEX |
3B5G | A:; B: | CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2 |
3B9V | A:; B:; C:; D: | CRYSTAL STRUCTURE OF AN AUTONOMOUS VH DOMAIN |
3BDX | A:; B:; C: | CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2 |
3BQU | A:1-107 | CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX |
3BX7 | C: | ENGINEERED HUMAN LIPOCALIN 2 (LCN2) IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HUMAN CTLA-4 |
3CDC | A:; B: | KI O18/O8 N34I/Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN |
3CDF | A:; D:; E:; F:; B:; C: | KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN |
3CDY | A:; B: | AL-09 H87Y, IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN |
3DVF | A: | STRUCTURE OF AMYLOIDOGENIC KAPPA 1 BENCE JONES PROTEIN |
3DVI | A: | CRYSTAL STRUCTURE OF KAPPA 1 AMYLOIDOGENIC LIGHT CHAIN VARIABLE DOMAIN |
3DX9 | A:2-125; C:2-125 | CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A |
3EYQ | C:1-108 | CRYSTAL STRUCTURE OF MJ5 FAB, A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 |
3F12 | A:1-108; C:1-108 | GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS |
3GSN | B:2-116 | CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE |
3H42 | L:1-112 | CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY |
3LRG | A:; B: | STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN |
3LRH | O: | STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN IN COMPLEX WITH HUNTINGTIN PEPTIDE |
3MLW | L:1-107; M:1-107 | CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE |
3OSK | A:; B: | CRYSTAL STRUCTURE OF HUMAN CTLA-4 APO HOMODIMER |
3P9W | B:; D:; F:; H: | CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF |
3Q6F | A:2-107; C:2-107; E:2-107; G:2-107; I:2-107; K:2-107 | CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120 |
3QCT | L:1-107 | CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT |
3QCU | L:1-107; M:1-107 | CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0) |
3QCV | L:1-107; M:1-107 | CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2) |
3QDG | D:1-110 | THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE |
3QDJ | D:1-110 | THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE |
3QEG | L:1-107 | CRYSTAL STRUCTURE OF HUMAN N12-I2 FAB, AN ADCC AND NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY |
3QEU | A:1-110; D:0-110 | THE CRYSTAL STRUCTURE OF TCR DMF5 |
3QH3 | A:1-111; C:1-111 | THE CRYSTAL STRUCTURE OF TCR A6 |
3REV | B:3-115 | CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20 |
3RRQ | A: | CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN PD-1 |
3SDY | L:1-107 | CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ |
3SO3 | B:1-106A | STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON-CANONICAL MECHANISM OF INHIBITION. |
3U79 | A:; B:; C:; D:; E:; F:; G:; H: | AL-103 Y32F Y96F |
3U7A | A: | AL-09 Y32F Y96F |
3UPA | A:; B: | A GENERAL STRATEGY FOR THE GENERATION OF HUMAN ANTIBODY VARIABLE DOMAINS WITH INCREASED AGGREGATION RESISTANCE |
3UPC | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | A GENERAL STRATEGY FOR THE GENERATION OF HUMAN ANTIBODY VARIABLE DOMAINS WITH INCREASED AGGREGATION RESISTANCE |
3ZHD | A:; B: | THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-4 SCAFFOLD. |
3ZHK | A: | THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 2X1 SCAFFOLD |
3ZHL | A: | THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 8-14 SCAFFOLD |
4AIX | A:; B:; C:; D: | CRYSTALLOGRAPHIC STRUCTURE OF AN AMYLOIDOGENIC VARIANT, 3RC34Y, OF THE GERMINAL LINE LAMBDA 3 |
4AJ0 | A:; B:; C:; D: | CRYSTALLOGRAPHIC STRUCTURE OF AN AMYLOIDOGENIC VARIANT, 3RCW, OF THE GERMINAL LINE LAMBDA 3 |
4AM0 | B:1-107; D:1-107; F:1-107; L:1-107 | STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12 |
4DN3 | L:1-108 | CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888 |
4FQL | L:1-107 | INFLUENZA B HA ANTIBODY (FAB) CR8033 |
4FQQ | A:3-108; C:3-108; E:3-108; L:3-108 | CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB |
4GKZ | A:0-115; B:2-114 | HA1.7, A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ |
4GRM | A:2-117; C:1-117 | THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6 |
4HWE | L:1-104 | CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT |
4JDV | B:2-103; L:1-103 | CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB |
4JFH | D:1-110 | HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX |
4JM2 | C:1-109 | CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB |
4K07 | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | CRYSTAL STRUCTURE OF THE AMYLOID-FORMING IMMUNOGLOBULIN AL-103 CIS-PROLINE 95 MUTANT |
4K3G | A:; B: | IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATING PROTEIN |
4K3H | A:; B:; C:; D:; E:; F:; G:; H: | IMMUNOGLOBULIN LAMBDA VARIABLE DOMAIN L5(L89S) FLUOROGEN ACTIVATIONG PROTEIN IN COMPLEX WITH MALACHITE GREEN |
4KFZ | C:; D: | CRYSTAL STRUCTURE OF LMO2 AND ANTI-LMO2 VH COMPLEX |
4MWF | B:3-107; L:2-107 | STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C |